Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.49T
Total marketcap
$185.9B
Total volume
BTC 60.58%     ETH 7.18%
Dominance

GlycoMimetics GLYC Stock

0.18 USD {{ price }} -2.755266% {{change_pct}}%
Exchange
NasdaqCM
Market Cap
11.61M USD
LOW - HIGH [24H]
0.18 - 0.2 USD
VOLUME [24H]
883.47K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.59 USD

GlycoMimetics Price Chart

GlycoMimetics GLYC Financial and Trading Overview

GlycoMimetics stock price 0.18 USD
Previous Close 0.27 USD
Open 0.27 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.26 - 0.27 USD
52 Week Range 0.14 - 3.5 USD
Volume 238.36K USD
Avg. Volume 20.76M USD
Market Cap 17.57M USD
Beta (5Y Monthly) 1.842
PE Ratio (TTM) N/A
EPS (TTM) -0.59 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 1 USD

GLYC Valuation Measures

Enterprise Value 3.82M USD
Trailing P/E N/A
Forward P/E -3.0255554
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1757.2336
Price/Book (mrq) 0.4561139
Enterprise Value/Revenue 381.762
Enterprise Value/EBITDA -0.094

Trading Information

GlycoMimetics Stock Price History

Beta (5Y Monthly) 1.842
52-Week Change -91.56%
S&P500 52-Week Change 23.80%
52 Week High 3.5 USD
52 Week Low 0.14 USD
50-Day Moving Average 0.29 USD
200-Day Moving Average 0.42 USD

GLYC Share Statistics

Avg. Volume (3 month) 20.76M USD
Avg. Daily Volume (10-Days) 175.61K USD
Shares Outstanding 64.53M
Float 42.53M
Short Ratio 1.07
% Held by Insiders 3.12%
% Held by Institutions 47.91%
Shares Short 5.64M
Short % of Float 12.60%
Short % of Shares Outstanding 8.74%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2023
Most Recent Quarter (mrq) June 30, 2024
Next Fiscal Year End December 31, 2024

Profitability

Profit Margin 0%
Operating Margin (ttm) -408770.50%
Gross Margin 100.00%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -59.24%
Return on Equity (ttm) -104.49%

Income Statement

Revenue (ttm) 10K USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 10K USD
EBITDA -40783964 USD
Net Income Avi to Common (ttm) -39113232 USD
Diluted EPS (ttm) -0.62
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 22.39M USD
Total Cash Per Share (mrq) 0.35 USD
Total Debt (mrq) 448.78K USD
Total Debt/Equity (mrq) 2.24 USD
Current Ratio (mrq) 5.477
Book Value Per Share (mrq) 0.597

Cash Flow Statement

Operating Cash Flow (ttm) -35700392 USD
Levered Free Cash Flow (ttm) -22150632 USD

Profile of GlycoMimetics

Country United States
State MD
City Rockville
Address 9708 Medical Center Drive
ZIP 20850
Phone 240 243 1201
Website https://www.glycomimetics.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 35

GlycoMimetics, Inc., a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. It develops uproleselan, an E-selectin antagonist, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as completed phase 3 trial to treat relapsed/refractory AML. The company also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and GMI-2093, a galectin-3 carbohydrate-binding protein. In addition, its portfolio comprises GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of osteosarcoma. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.

Q&A For GlycoMimetics Stock

What is a current GLYC stock price?

GlycoMimetics GLYC stock price today per share is 0.18 USD.

How to purchase GlycoMimetics stock?

You can buy GLYC shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for GlycoMimetics?

The stock symbol or ticker of GlycoMimetics is GLYC.

Which industry does the GlycoMimetics company belong to?

The GlycoMimetics industry is Biotechnology.

How many shares does GlycoMimetics have in circulation?

The max supply of GlycoMimetics shares is 64.51M.

What is GlycoMimetics Price to Earnings Ratio (PE Ratio)?

GlycoMimetics PE Ratio is now.

What was GlycoMimetics earnings per share over the trailing 12 months (TTM)?

GlycoMimetics EPS is -0.59 USD over the trailing 12 months.

Which sector does the GlycoMimetics company belong to?

The GlycoMimetics sector is Healthcare.

GlycoMimetics GLYC included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 15587.79 USD
-5.82
9.14B USD 15575.68 USD 16128.16 USD 9.14B USD
NASDAQ Composite Total Return I XCMP 19079.55 USD
-5.82
19064.73 USD 19740.96 USD
NASDAQ Global Market Composite NQGM 1647.83 USD
-5.17
1610.28 USD 1681.06 USD
NASDAQ HealthCare IXHC 869.8 USD
-5.51
868.74 USD 900.72 USD